Today, I link to and embed Metabolic Mind CME‘s “The Evidence Supporting Ketogenic Therapy for the Treatment of Serious Mental Illness“.
All that follows is from the above resource.
Program Description
The purpose of this CME activity is to educate practicing physicians and other healthcare professionals about the most recent clinical trials and case series in the field of metabolic psychiatry. This emerging evidence suggests that nutritional ketosis may be a powerful tool as an adjunct to standard medical management of severe mental illness (e.g. bipolar, schizophrenia, depression). By demonstrating that the body of evidence in this field is increasing, we hope to persuade clinicians to consider this type of dietary therapy as an option in the care of their patients.
Educational Objectives
Upon completion of the educational activity, participants should be able to:
- Explain the purported mechanisms for a connection between metabolic and mental health.
- Describe why metformin can also improve the symptoms of bipolar depression by improving insulin resistance.
- Describe the findings of a paper showing that inpatient initiation of a ketogenic diet improved psychiatric symptoms and medication usage for patients with bipolar disorder, major depression, and schizophrenia.
- Describe the findings of a study showing that outpatient use of ketogenic diets improved metabolic health and psychiatric symptoms in patients with bipolar disorder and schizophrenia.
- Incorporate acquired knowledge on the latest findings on ketogenic therapy for serious mental illness into current practice to better address the needs of their patients, and to optimize patient outcomes.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of Metabolic Health Initiative (MHI). The Metabolic Health Initiative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation Statement
Metabolic Health Initiative designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty
Matthew Bernstein, MD
Chief Medical Officer, Ellenhorn LLC
Chief Executive Officer & Chief Medical Officer, Accord Mental Health LLC
Lecturer in Psychiatry, Harvard Medical School
Boston MassachusettsDr. Bernstein has no relevant financial information to disclose (3/6/2025).
Bret Scher, MD
Medical Director, Baszucki Group and Metabolic Mind
San Mateo, CaliforniaDr. Scher has no relevant financial information to disclose (2/21/2025).
